ethinyl estradiol has been researched along with Brain Ischemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borges-Garcia, R; Bramlett, H; Diaz, F; Raval, AP; Sick, TJ | 1 |
Cole, JA; Doherty, M; Norman, H; Walker, AM | 1 |
Arbini, A; Mannucci, PM; Martinelli, I; Moia, M; Tripodi, A | 1 |
3 other study(ies) available for ethinyl estradiol and Brain Ischemia
Article | Year |
---|---|
Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain.
Topics: Animals; Brain Ischemia; Contraceptives, Oral, Combined; Cyclic AMP Response Element-Binding Protein; Drug Synergism; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Ethinyl Estradiol; Female; Ganglionic Stimulants; Mitochondria; Nicotine; Norgestrel; Phosphorylation; Rats; Receptors, Estrogen; Signal Transduction; Smoking | 2013 |
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Topics: Administration, Cutaneous; Brain Ischemia; Case-Control Studies; Cohort Studies; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Myocardial Infarction; Norgestrel; Stroke; Thromboembolism; Venous Thrombosis | 2007 |
Ischemic stroke in congenital (type II C) defective antithrombin III.
Topics: Adult; Antithrombin III Deficiency; Brain Ischemia; Ethinyl Estradiol; Female; Heterozygote; Humans; Levonorgestrel; Risk Factors | 1993 |